This document is posted to help you gain knowledge. Please leave a comment to let me know what you think about it! Share it to your friends and learn new things together.
Transcript
MicroDrug Class Usepenicillin B-lactam GP (not Staph), Syph
nafcillin S. aureus (not MRSA)dicloxacillinmethicillinampicillin aminoPCNamoxicillinticarcillin Pseudomonas (+AG) and GNRpiperacillin Pseudomonas (+AG) and GNRcarbenicillin Pseudomonas (+AG) and GNRclavulanic acidsulbactamtazobactamcefazolin 1G ceph GPC, Proteus, E. coli, K. pneumocephalexin 1G cephcefoxitin 2G cephcefalcor 2G cephcefuroxime 2G cephceftriaxone 3G ceph
ceftazidime 3G ceph Pseudomonascefipime 4G ceph Pseudomonas and GPaztreonam monobactam GNRs ONLY (no anaerobes)
gentamicin AG GNR, synergistic w/ B-lactamsamikacin AG GNR, synergistic w/ B-lactamstobramycin AG GNR, synergistic w/ B-lactamsneomycin AG bowel surgery
doxycycline tetracyclinedemeclocycline tetracycline +ADH antagonist (diuretic in SIADH)minocycline tetracycline +meningococcal prophylaxis (2nd line)erythromycin macrolideclarithromycin macrolideazithromycin macrolidechloramphenicol meningitis (H. flu, N. meningitides, S. pneumo)
clindamycin lincosamide anaerobes in aspiration pneumonia
PCNase-resistant PCN
certain GPs (Listeria, enterococci) and GNRs (Proteus, H. flu, E. coli, Salmonella)
extended spectrum PCN
B-lactamase inhibitor
GPC, Proteus, E. coli, K. pneumo, H. flu, Enterobacter, Neisseria, Serratia
Neisseria, gonorrhea prophylaxis, H. flu meningitis
fluconazole azole Cryptococcal meningitis in AIDS, Candidaflucytosine systemic infxn along with Amphotericin Bcaspofungin Invasive Aspergillosisterbinafinegriseofulvin
pyrimethamine antiprotozoan P. falciparum, +sulfadiazine=toxosuramin antiprotozoan Trypanosomes, no CNS penetrationmelacortin antiprotozoan Trypanosomes, CNS penetrationnifurtimox antiprotozoan T. cruziNa stibogluconate antiprotozoan Leishmaniasischloroquine antiprotozoan Plasmodiummefloquine antiprotozoan Plasmodium (resistant to chloroquine)quinine antiprotozoan chloroquine-resistant Plasmodium when used with pyrimethamine and sulfonamide; Babesia
sulfonamide I
UTIs (tx or prophylactic for recurrent), Shigella, Salmonella, PCP (tx/prophylaxis)
GI protozoa (Giardia, Entamoeba), vaginal (Trichomonas, Gardnerella), anaerobes
M. leprae (delays resistance to dapsone), prophylactic for H. flu and N. meningitides; M. TB (quad tx)
zanamivir influenza A and Boseltamivirribavirin RSV, chronic hep Cacyclovir HSV (tx and prophylaxis), VZV, EBVfamciclovir herpes zostergangciclovir CMV (mostly in immunocompromised)foscarnet
saquiNAVIR protease I HIVindiNAVIR protease I HIVdidanosine (ddI) HIVzalcitabine (ddC) HIVstavudine (d4T) HIVzidovudine (ZDV) HIV (tx, prophylaxis, pregnancy)nevirapine NNRTI HIVefavirenz NNRTI HIVdelaviridine NNRTI HIVenfuvirtide fusion inhibitor
HIV (used in pts w/ persistent viral replication despite HAART)
chronic hep B/C, Kaposi's sarcoma, leukemias, malignant melanoma
Binds cyclophilins, inhibits calcineurin preventing IL-2 and IL-2R production
Binds FK-BP, inhibits IL-2 and IL-2R production (and other cytokines)
antimetabolite precursor to 6-MP (interferes w/ nucleic acid synth)
muromonab-CD3 (OKT-3)
MAb that binds CD3 (epsilon chain) on TC, blocks signal transduction
filgrastim recombinant Granulocyte Colony Stimulating Factorsargramostim recombinant GMacrophage-CSFoprelvekin recombinant IL-11thrombopoietin recombinant thrombopoetindigoxin immune Fab therapeutic abetanercept recombinant form of TNF-R (sequesters TNF)infliximab therapeutic ab anti-TNF-α
adalimumab therapeutic ab anti-TNF-αPharm/Cardio
Drug Class Mechanismmetyrosine inhibits tyrosine hydroxylase (makes DOPA)guanethidine inhibits NE release (replaces it in vescicles)carbachol direct ACh agpilocarpine direct ACh ag
bethanechol direct ACh ag ACh ag, resistant to AChEmethacholine direct ACh ag inhaled, causes bronchoconstrictionedrophonium AChEI extremely short actingneostigmine AChEI no CNS penetration
pyridostigmine AChEI no CNS penetration, long actingphysostigmine AChEI CNS penetrationechothiophate AChEI CNS penetrationtropicamide ACh ant in eyeatropine ACh ant
pralidoxime regenerates AChEscopolamine ACh ant CNSipratropium ACh ant competitive block of MACh-Roxybutynin ACh ant GUglycopyrrolate ACh antmethsopolamine ACh antpirenzepine ACh antpropantheline ACh anthexamethonium nicotinic ag ganglionic blockerepinephrine Symp ag
NE Symp ag α>β1isoproterenol Symp ag βDA Symp ag D>β>α, inotropic and chronotropicdobutamine Symp ag β1>β2, inotropicphenylephrine Symp ag α1>α2
ACh ag, resistant to AChE; contract ciliary m and increase outflow of aq humor
GI (block M1R on ECL cells [decrease histamine] and M3R on parietal cells [decrease H secretion])
vasoconstriction decreases aq humor production; low dose: β>α; high: α>β
metaproterenol Symp ag selective β2 ag (β2>>β1)albuterolsalmeterolephedrine release stored catecholaminescocaine
diltiazem (non-DHP) reduce mm contractility, ventricle<vessels
nitroglycerin venodilatorisosorbide dinitrate venodilatornitroprusside short acting, same as nitroglycerinfenoldopam D1 ag, relaxes renal vascular smooth mdiazoxide K-ch opener hyperpolarizes/relaxes vascular smooth m -statin HMG-CoA RI inhibits chlsl to mevalonateniacin B3
cholestyramine bile acid resincolesevelamezetimibe prevents chlsl reabs at small intestine brushgemfibrozil fibrate upregulate LPL causing increased TG Cl.
catecholamine reuptake inhibitor, inactivates Na channels
central α2 ag, decrease central adrenergic outflow
AND class II anti-arrhythmics
increased cGMP, relaxing smooth m; arterioles>veins, afterload reduction
reduce mm contractility, ventricle=vessels; nitrate-like antianginal (L-type) CCB
+type IV anti-arrhythmic
reduce mm contractility, ventricle>vessels; β-blocker-like antianginal
release NO in smooth m causing increased cGMP, veins>aa, decrease preload
decreases hepatic VLDL secretion into circ, inhibit lipolysis in adipose tissue
prevents intestinal reabs of bile acids, liver uses chlsl to make more
GIDrug Class MechanismfamoTIDINEraniTIDINEcimeTIDINEnizaTIDINEomeprazole PPI irreversibly inhibit H/K ATPase in parietal cellslansoprazolebismuthsucrasulfate
misoprostol
Al(OH)3 antacidMg(OH)2CaCO3sulfasalazine
ondansetron 5HT3 ant, powerful central antiemeticmetoclopramide
Heme/OncDrug Class Mechanismheme and glucose inhibits ALA synthase(RLS of heme synth)pyridoxamine (B6)vitamin A (xs)
heparin
decreases gluconeogenesis, increase glycolysis and peripheral glucose uptake
tPAurokinasestreptokinase bind w/ plasminogen, activate plasminogenanistreplase streptokinase bound to plasminogenclopidogrelticlopidineabciximab therapeutic ab glycoprotein IIb/IIIa Ab for activated platelets
methotrexate (MTX)
5-FU
6-MP6-thioguanine (6TG)cytarabine (ara-C) pyrimidine analog, inhibits DNA Poldactinomycin antitumor abx intercalates DNA
daunorubicinbleomycin free radical formation, breaks DNA (G2)(eto)-POSIDE (VP-16) inhibits topoisomerase II (S and G2)cyclophosphamide alkylating agentsifosfamide
bromocriptine DA ag (ergot derivative)pramipexole DA ag (non-ergot derivative, so preferred)ropiniroleamantidine increases DA releaselevodopa/carbidopa
inhibits HVA Ca channels (designed as GABA analog)
propagates GABAA action by increasing duration Cl channel is open
high potency, highly lipid soluble; decreases cerebral blood flow
increased Na channel inactivation, increase GABA concentration
MgSO4
increase frequency of Cl channel opening causing propagation of GABAA action; decrease REM
act via BZ1 receptor subtype; reversed by flumazenil
unknown; high blood solubility=slower induction and recovery time; high lipid solubility=high potency=lower MAC
potentiates GABAA
motor nACh-R blocker
phase I=prolonged depol (no antidote, potentiated by neostigmine); II=repol but blocked (antidote=neostigmine)
compete for AChRs, reversible w/ cholinesterase inhibitors
prevents release of Ca from sarcoplasmic reticulum of skeletal mm
converted to DA in CNS; carbidopa= peripheral dopa-decarboxylase inhibitor
reserpine
tetrabenazine amine depleting (DA)memantine NMDA-R ant (prevent excitotoxicity)rivastigmine AChEIdonepezilgalantaminesumatriptan
PsychDrug Class Mechanismthioridazine
chlorpromazinetrifluoperazinefluphenazinehaloperidolquetiapine block 5-HT2, DA, α, and H1 receptorsreisperidonearipiprazoleziprasidoneclozapineolanzapinelithium mood stabilizer
buspirone
desipramineamitriptylinenotriptylineimipramineclomipramine(flu)-OXETINE SSRIsertralinecitalopramvenlafaxine SNRI 5-HT>NE reuptake inhibitorduloxetine 5-HT<NE reuptake inhibitoratomoxitene 5-HT and NE reuptake inhibitor, nonstimulantphenelzine MAOI nonselective MAOI, increase NE, 5HT, DAtranylcypromineisocarboxazidselegiline selective MAO-BI (main metabolyzer of DA)bupropion increased NE and DAmirtazapine
inhibits DA, NE, and 5HT into vescicles (amine depleting)
5HT1B, 1D ag causes vasoconstriction, inhibits V activation and VIP release; short t1/2 (<2h)
antipsychotic (typical, neuroleptic)
block D2R, but can also block muscarinic, α, and histamine receptors, all low potency; highly lipid soluble (long t1/2)
block D2R, high potency; highly lipid soluble (long t1/2)
atypical antipsycotics
unknown (maybe inhibits PI3 cascade), ADH antagonist; exclusively excreted by kidneys, most reabsorbed at PCT with Na
cilastatin=renal dehydropeptidase I inhibitor, decreases inactivation of drug; seizures, GI distress, rash
inhibits cell wall mucopeptide formation by binding D-ala D-ala portion of precursors
bind 30S, inhibit initiation complex, cause misreading of mRNA; require O2 for uptake (no anaerobes); modifying transferase enzymes (acetylation) can lead to resistance
binds 30S and prevents attachment of AA-tRNA; resistance by decreased uptake or increased efflux by pumps (plasmid-encoded); do not take w/ milk, antacids, or Fe (divalent cations inhibit abs)
inhibits 50S peptidyltransferase; plasmid-encoded acetyltransferase inactivates drug
bacterial DHFRase I
free radical toxic metabolites that damage DNA
disrupts membranes (basic cations=detergent)
DNA-dep RNA pol inhibitor
same as amphotericin B
converted to 5FU, inhibits DNA synthβ-glucan cell wall synthesis inhibitorsqualine epoxidase I (ergosterol precursor)
inhibits plasmodial DHFRaseinhibits energy metabolism enzymesinhibits sulfhydryl enzymesforms intracellular oxygen radicalsinhibits glycolysis at PFK
chloroquine-resistant Plasmodium when used with pyrimethamine and sulfonamide; Babesia
topoisomerase II inhibitor; resistance=mutated DNA gyrase
decreased synth of mycolic acid, activated by bacterial catalase-peroxidase
binds ergosterol, forms pores in membrane; does not cross BBB (intrathecal for meningitis)
inhibit fungal ergosterol synthesis by inhibiting P450 enzyme (lanosterol 14-α-demethylase); for systemic mycoses; ketoconazole also inhibits human enzyme desmolase (T-synth)
microtubule inhibitor, deposits in keratin-containing tissues
blocks plasmodium heme polymerase (buildup of toxic hemoglobin products)
inhibits glucose uptake and microtubule synthstimulates depolarization-induced paralysis by stimulating nicotinic receptors at NMJamplifies GABA-mediated inhibition leading to immobilization; doesn't cross BBB (no effect on humans)
increases membrane permeability to Ca (contraction, paralysis)
dehydropeptidase I stable, lower risk of seizures; GI distress, skin rash
+fecally eliminated (can be used in pts w/ renal failure) +diabetes insipidus
bacteriocidal; G=IV, V=oral; can cause hypersensitivity rxn (all PCNs) or hemolytic anemia, SJS
Hypersensitivity (cross hypersensitivity with PCNs in 5-10%), vitamin K deficiency, disulfiram-like rxn with EtOH (only in some cephalosporins), increase nephrotoxicity of aminoglycosides
no cross-allergenicity w/ PCN or cephalosporins, good in renal insufficiency; occasional GI upset
cilastatin=renal dehydropeptidase I inhibitor, decreases inactivation of drug; seizures, GI distress, rash
rarely SFx: nephrotoxicity + ototoxicity, thrombophlebitis, "red man syndrome" (preventable by slow infusion)
nephrotoxic (especially when used w/ cephalosporins), ototoxic (especially when used w/ loop diuretics), teratogenic (CN VIII agenesis)
GI distress, teratogen (teeth discoloration), bone growth inhibition in kids, hypersensitivity; expired causes Fanconi's
prolonged QT, GI discomfort, acute cholestatic hepatitis (avoid in liver disease), eosinophilia, skin rashes; P450 down (increases efficacy of theophylline and oral anticoagulants)
anemia (dose dependent), aplastic anemia (dose ind), gray baby sz (in preemies, lack of UDP-glucuronyl transferase)
stimulates depolarization-induced paralysis by stimulating nicotinic receptors at NMJamplifies GABA-mediated inhibition leading to immobilization; doesn't cross BBB (no effect on humans)
increases membrane permeability to Ca (contraction, paralysis)ataxia, dizziness, slurred speech
hemolytic anemia, teratogen (severe)no effect on latent virus; resistance=lack of viral thymidine kinase
thrombocyto-/leuko-/neutro-penia, nephrotoxicnephrotoxic; resistance by mutated DNA pol
+thrombocytopenia
+megaloblastic anemia
hypersensitivity, increased risk of bacterial pneumonia
exacerbation of COPD, asthma, and peptic ulcers; severe/OD on AChEI: DUMBBELS=diarrhea, urination, miosis, bradycardia, bronchospasm, excitation of CNS and skeletal mm, lacrimation, sweating, salivation
impotence, exacerbation of asthma, CV effects (bradycardia, AV block, CHF), CNS effects (sedation, sleep alteration), caution in DM (tx OD w/ glucagon), partial agonists (pindolol and acebutolol) contraindicated in angina; metoprolol can cause dyslipidemia
reflex tachycardia (contraindicated in angina/CAD, commonly given w/ β-blocker), Lupus-like sz
cutaneous flushing, cardiac depression, AV block, peripheral edema, dizziness, constipation
reflex tachycardia, hypotension, flushing, headache (esp when used on Monday after loss of tolerance over weekend; tolerance common)
higher risk of thrombosis, sulfa allergy, lower incidence of GI sfx
corrosive esophagitis, N/D, osteonecrosis of jaw no corrosive esophagitis (IV)
NeuroSFX/otherno pupillary or vision changesdarkens iris
similar to opioids, decreases seizure thresholdless respiratory depression, causes withdrawal if on full ag
SJS
all NSAIDs: inhibit dilation of afferent arteriole, drop GFR (acute renal failure), intersitial nephritis and aplastic anemia; hemolytic anemia in G6PDD, gastric upset/ulceration, UGI bleed, tinnitus (CN VIII); Reye's syndrome in kids (esp w/ viral infxn)
interstitial nephritis, aplastic anemia, fluid retention, GI distress, ulcers; ibuprofen: hemolytic anemia in G6PDD
no Reye's sz, but OD causes hepatic necrosis (metabolyte depletes glutathione and forms toxins in liver), N-acetylcysteine is antidote
GI side effects, agranulocytosis
SJS, increases concentrations of azathioprine and 6-MP (both metabolyzed by xanthine oxidase, give 6-tG instead of 6-MP)
Respiratory depression, miosis (pinpoint pupils), additive CNS depression with other drugs, addiction, constipation, N/V; tolerance does not develop to miosis and constipation; -OD (life-threatening) txed w/ naloxone or naltrexone (opioid ant) -withdrawal: sweating, dilated pupils, piloerection ("cold turkey"), fever, rhinorrhea, N/D/stomach cramps (flu-like); symptomatic tx -heroin: high risk for hepatitis, abscess, OD, hemorrhoids, AIDS, RHF
GI distress, hepatotoxicity/necrosis (can be fatal, measure LFTs), teratogen (neural tube defects), tremor, weight gain
fatigue, GI distress, headache, urticaria, SJS
much larger safety margin than barbiturates, and less respiratory depression; usually long t1/2 and active metabolites (short acting BDZs have higher addictive potential); sedation, tolerance, dependence, CNS depression (additive w/ EtOH); OD: ataxia, minor respiratory depression; tx=flumazenil (competitive antagonist at GABA-R)
short t1/2 (rapidly degraded in liver), so less day-after SFX; ataxia, headaches, confusion; lower dependence risk than BDZ
hepatotoxicity/necrosis, malignant hyperthermia (all but N2O)
arrhythmias from peripheral conversion to DA; long term can cause dyskinesia following dose, akinesia between doses
less than TCAs: GI distress, sexual dysfunction, "Seratonin sz" (drug interactions, too much 5-HT causes HyperThermia, HyperTonism, CV collapse, flushing, diarrhea, seizures; tx=cyprohepadine [5HT2 ant])
htnsive crisis (w/ tyramine ingestion and beta-ag), CNS stimulation, contraindicated w/ SSRIs or meperidine (prevent seratonin sz)
stimulant effects (tachycardia, insomnia), headache, seizure in bulimia
Cardiodisease txessential htn diuretics, ACEI, ARBs, CCBhtn in CHF diuretics, ACEI, ARBs, CCB, β blockershtn in DM ACEI, ARBs, CCB, diuretics, β-blocker, α-blockermalignant htn nitroprusside, fenoldopam, diazoxideangina nitrates and β-blockersAFib digoxin, β-blockers, anticoag, non-DHPAFlutter ablation, anticoag, non-DHPSVT class IA/C, class II, class IV, adenosineVT class I, class II
Neurodisease txtonic clonic seizure first line: phenytoin, carbamazepine, valproateabsence seizure first line: ethosuximide; otherwise, valproatestatus seizure acute: BDZ; prophylaxis: phenytoin
Cardioother
no β blockers in decompensated CHF, esp K-sparing diureticsACEI protective against diabetic nephropathy
Neuro
first line in pregnancy and children: phenobarbital
NeuroName SxHuntington
Parkinson
Alzheimer dementia, can get intracranial hemorrhage
Pick's Dz (FTD)
LBD Parkinsonism w/ dementia and hallucinationsCJD rapidly progressive dementia with myoclonusNPH urinary incontinence, ataxia, dementia